SG11201901000XA - Compositions and methods of cell attachment - Google Patents
Compositions and methods of cell attachmentInfo
- Publication number
- SG11201901000XA SG11201901000XA SG11201901000XA SG11201901000XA SG11201901000XA SG 11201901000X A SG11201901000X A SG 11201901000XA SG 11201901000X A SG11201901000X A SG 11201901000XA SG 11201901000X A SG11201901000X A SG 11201901000XA SG 11201901000X A SG11201901000X A SG 11201901000XA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- pct
- street
- compositions
- methods
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 210000004027 cell Anatomy 0.000 abstract 2
- 230000006870 function Effects 0.000 abstract 2
- 235000014036 Castanea Nutrition 0.000 abstract 1
- 241001070941 Castanea Species 0.000 abstract 1
- FVIGODVHAVLZOO-UHFFFAOYSA-N Dixanthogen Chemical compound CCOC(=S)SSC(=S)OCC FVIGODVHAVLZOO-UHFFFAOYSA-N 0.000 abstract 1
- 230000024245 cell differentiation Effects 0.000 abstract 1
- 229960002377 dixanthogen Drugs 0.000 abstract 1
- 210000005228 liver tissue Anatomy 0.000 abstract 1
- 210000004962 mammalian cell Anatomy 0.000 abstract 1
- 210000003205 muscle Anatomy 0.000 abstract 1
- 230000008520 organization Effects 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 125000006850 spacer group Chemical group 0.000 abstract 1
- 230000002459 sustained effect Effects 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 abstract 1
- 230000035899 viability Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5032—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on intercellular interactions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/02—Form or structure of the vessel
- C12M23/16—Microfluidic devices; Capillary tubes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/20—Material Coatings
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M25/00—Means for supporting, enclosing or fixing the microorganisms, e.g. immunocoatings
- C12M25/02—Membranes; Filters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0068—General culture methods using substrates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0658—Skeletal muscle cells, e.g. myocytes, myotubes, myoblasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/067—Hepatocytes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2521/00—Culture process characterised by the use of hydrostatic pressure, flow or shear forces
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/30—Synthetic polymers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/52—Fibronectin; Laminin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/54—Collagen; Gelatin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2535/00—Supports or coatings for cell culture characterised by topography
- C12N2535/10—Patterned coating
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2537/00—Supports and/or coatings for cell culture characterised by physical or chemical treatment
- C12N2537/10—Cross-linking
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Sustainable Development (AREA)
- Toxicology (AREA)
- Medicinal Chemistry (AREA)
- Clinical Laboratory Science (AREA)
- Rheumatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Dispersion Chemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Prostheses (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662361259P | 2016-07-12 | 2016-07-12 | |
PCT/US2017/041762 WO2018013718A1 (en) | 2016-07-12 | 2017-07-12 | Compositions and methods of cell attachment |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201901000XA true SG11201901000XA (en) | 2019-03-28 |
Family
ID=59676739
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201901000XA SG11201901000XA (en) | 2016-07-12 | 2017-07-12 | Compositions and methods of cell attachment |
Country Status (7)
Country | Link |
---|---|
US (7) | US11536714B2 (de) |
EP (1) | EP3484991A4 (de) |
AU (1) | AU2017297408A1 (de) |
CA (1) | CA3032997A1 (de) |
GB (2) | GB2584973B (de) |
SG (1) | SG11201901000XA (de) |
WO (1) | WO2018013718A1 (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3032997A1 (en) * | 2016-07-12 | 2018-01-18 | EMULATE, Inc. | Compositions and methods of cell attachment |
WO2019014441A1 (en) * | 2017-07-12 | 2019-01-17 | EMULATE, Inc. | SURFACE FUNCTIONALIZATION |
US11518971B2 (en) * | 2018-11-27 | 2022-12-06 | Research Triangle Institute | Method and apparatus for spatial control of cellular growth |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7160687B1 (en) | 1997-05-29 | 2007-01-09 | Cellomics, Inc. | Miniaturized cell array methods and apparatus for cell-based screening |
US7453486B2 (en) * | 2000-12-13 | 2008-11-18 | Orbotech Ltd | Pulse light pattern writer |
JP2005509882A (ja) | 2001-11-20 | 2005-04-14 | バースタイン テクノロジーズ,インコーポレイティド | 細胞分析のための光バイオディスクおよび流体回路ならびにそれに関連する方法 |
JP2008545410A (ja) * | 2005-05-24 | 2008-12-18 | ザ レジェンツ オブ ザ ユニヴァースティ オブ カリフォルニア | 微小規模のマイクロパターン化インビトロ操作・作製組織 |
US8993312B2 (en) * | 2007-08-30 | 2015-03-31 | President And Fellows Of Harvard College | Bio-matrix stretcher |
ES2672201T3 (es) | 2008-07-16 | 2018-06-13 | Children's Medical Center Corporation | Dispositivo de imitación de órganos con microcanales y métodos de uso |
US9115340B2 (en) * | 2008-08-08 | 2015-08-25 | Agency For Science Technology & Research | Microfluidic continuous flow device |
US9040665B2 (en) * | 2008-09-30 | 2015-05-26 | Case Western Reserve University | Controlled cross-linking processing of proteins |
FR2937050A1 (fr) * | 2008-10-10 | 2010-04-16 | Inst Curie | Dispositif de culture cellulaire |
US20100135855A1 (en) * | 2008-11-26 | 2010-06-03 | Koninklijke Philips Electronics N.V. | Method for depositing substances on a support |
US8628572B2 (en) | 2009-02-26 | 2014-01-14 | Wake Forest University Health Sciences | Corneal endothelial scaffolds and methods of use |
US20120135446A1 (en) * | 2009-03-04 | 2012-05-31 | Maine Institute For Human Genetics & Health, Inc | Microfluidic Device and Related Methods |
WO2013086502A1 (en) | 2011-12-09 | 2013-06-13 | President And Fellows Of Harvard College | Organ chips and uses thereof |
SE538193C2 (sv) * | 2012-07-05 | 2016-03-29 | Scania Cv Ab | SCR-system och förfarande vid ett SCR-system |
WO2014143998A1 (en) * | 2013-03-15 | 2014-09-18 | The Broad Institute | Systems and methods for culturing epithelial cells |
CA2922247C (en) * | 2013-08-28 | 2023-03-07 | Promethera Biosciences S.A./N.V. | Method for producing adult liver progenitor cells |
EP3063262A4 (de) | 2013-10-30 | 2017-07-19 | Miklas, Jason | Vorrichtungen und verfahren für eine dreidimensionale gewebekultur |
GB2581749B (en) | 2013-12-20 | 2021-03-03 | Harvard College | Organomimetic devices and methods of use and manufacturing thereof |
CN106459898A (zh) | 2013-12-20 | 2017-02-22 | 哈佛大学校长及研究员协会 | 低剪切微流控装置及其使用方法和制造方法 |
SG11201605785XA (en) * | 2014-01-14 | 2016-08-30 | Univ Colorado State Res Found | Stem cell-derived hepatocytes in co-culture and uses thereof |
WO2016004394A1 (en) | 2014-07-03 | 2016-01-07 | Texas Tech University System | Microfluidic cardiovascular system and method |
WO2016054288A1 (en) * | 2014-09-30 | 2016-04-07 | Taylor Lansing D | A human liver microphysiology platform and self assembly liver acinus model and methods of their use |
CA2993956A1 (en) * | 2015-07-27 | 2017-02-02 | The Trustees Of The University Of Pennsylvania | Lung disease models on a chip |
US20170158997A1 (en) * | 2015-12-04 | 2017-06-08 | President And Fellows Of Harvard College | Devices for simulating a function of a liver tissue and methods of use and manufacturing thereof |
CA3032997A1 (en) * | 2016-07-12 | 2018-01-18 | EMULATE, Inc. | Compositions and methods of cell attachment |
-
2017
- 2017-07-12 CA CA3032997A patent/CA3032997A1/en active Pending
- 2017-07-12 AU AU2017297408A patent/AU2017297408A1/en not_active Abandoned
- 2017-07-12 US US15/648,213 patent/US11536714B2/en active Active
- 2017-07-12 GB GB2014449.9A patent/GB2584973B/en active Active
- 2017-07-12 US US15/648,306 patent/US11549937B2/en active Active
- 2017-07-12 EP EP17828406.3A patent/EP3484991A4/de active Pending
- 2017-07-12 US US15/648,293 patent/US11506652B2/en active Active
- 2017-07-12 US US15/648,352 patent/US11506653B2/en active Active
- 2017-07-12 US US15/648,319 patent/US11519903B2/en active Active
- 2017-07-12 WO PCT/US2017/041762 patent/WO2018013718A1/en unknown
- 2017-07-12 US US15/648,339 patent/US11733234B2/en active Active
- 2017-07-12 SG SG11201901000XA patent/SG11201901000XA/en unknown
- 2017-07-12 GB GB1711206.1A patent/GB2558336B/en active Active
-
2023
- 2023-06-27 US US18/214,651 patent/US20230341378A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US11733234B2 (en) | 2023-08-22 |
GB2584973B (en) | 2021-04-14 |
EP3484991A4 (de) | 2020-03-18 |
US11506653B2 (en) | 2022-11-22 |
US11536714B2 (en) | 2022-12-27 |
US20230341378A1 (en) | 2023-10-26 |
US20180024119A1 (en) | 2018-01-25 |
CA3032997A1 (en) | 2018-01-18 |
GB2558336A (en) | 2018-07-11 |
GB2584973A (en) | 2020-12-23 |
GB202014449D0 (en) | 2020-10-28 |
US20180023050A1 (en) | 2018-01-25 |
US20180024116A1 (en) | 2018-01-25 |
WO2018013718A1 (en) | 2018-01-18 |
GB2558336B (en) | 2020-10-28 |
US20180024118A1 (en) | 2018-01-25 |
US11506652B2 (en) | 2022-11-22 |
AU2017297408A1 (en) | 2019-02-21 |
GB201711206D0 (en) | 2017-08-23 |
US20180024120A1 (en) | 2018-01-25 |
US20180024117A1 (en) | 2018-01-25 |
US11519903B2 (en) | 2022-12-06 |
EP3484991A1 (de) | 2019-05-22 |
US11549937B2 (en) | 2023-01-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11201804700VA (en) | Devices and methods for simulating a function of a liver tissue | |
SG11201901621VA (en) | Development of spinal cord on a microfluidic chip | |
SG11201804699WA (en) | Open-top microfluidic device with structural anchors | |
SG11201909501TA (en) | Personalized 3d neural culture system for generating human oligodendrocytes and studying myelination in vitro | |
SG11201809913PA (en) | Methods for detecting target nucleic acids in a sample | |
SG11201804710TA (en) | Devices for simulating a function of a liver tissue and methods of use and manufacturing thereof | |
SG11201810003UA (en) | Using programmable dna binding proteins to enhance targeted genome modification | |
SG11201407702XA (en) | Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription | |
SG11201908240YA (en) | Methods for evaluating tumor cell spheroids using 3d microfluidic cell culture device | |
SG11201810171SA (en) | Kras g12c inhibitors | |
SG11201910173YA (en) | Device and method for microfluidics-based 3d bioprinting | |
SG11201805451TA (en) | Immune effector cell therapies with enhanced efficacy | |
SG11201805420SA (en) | Antibodies and conjugates thereof | |
SG11201810780XA (en) | Single use bioreactor | |
SG11201807068WA (en) | Devices and methods for rapid pcr | |
SG11201809614VA (en) | Method for the fabrication of three-dimensional objects and apparatus for same | |
SG11201803703UA (en) | Anti-complement factor c1q fab fragments and uses thereof | |
SG11201807538PA (en) | Crispr-cpf1-related methods, compositions and components for cancer immunotherapy | |
SG11201901000XA (en) | Compositions and methods of cell attachment | |
SG11201900057WA (en) | Biomatrix scaffolds for use in diagnosing and modeling cancer | |
SG11201807041PA (en) | Improved preparations of adult liver progenitor cells | |
SG11201408405WA (en) | Engineered three-dimensional connective tissue constructs and methods of making the same | |
SG11201900081QA (en) | Removing bubbles in a microfluidic device | |
SG11201900058YA (en) | Method of generating mesenchymal stem cells and uses thereof | |
SG11201809515VA (en) | Charged isoporous materials for electrostatic separations |